Serum Institute seeks indemnity, wants equal treatment

Serum Institute of India (SII), which manufactures the Covishield Covid-19 vaccine, has sought indemnity against adverse reactions to its jabs, said people aware of the matter.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3g6MCXR
via IFTTT